Published in CNS Neurol Disord Drug Targets on June 01, 2011
Wnt signaling regulates postembryonic hypothalamic progenitor differentiation. Dev Cell (2012) 1.09
Nestin-expressing cells in the gut give rise to enteric neurons and glial cells. Neurogastroenterol Motil (2012) 1.03
Occurrence of new neurons in the piriform cortex. Front Neuroanat (2015) 0.86
Noncanonical Sites of Adult Neurogenesis in the Mammalian Brain. Cold Spring Harb Perspect Biol (2015) 0.85
Hypothalamic subependymal niche: a novel site of the adult neurogenesis. Cell Mol Neurobiol (2014) 0.82
Birth of neural progenitors during the embryonic period of sexual differentiation in the Japanese quail brain. J Comp Neurol (2012) 0.80
Detrimental role of prolonged sleep deprivation on adult neurogenesis. Front Cell Neurosci (2015) 0.76
Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link? Curr Neuropharmacol (2013) 0.75
The Role of Hypothalamic Neuropeptides in Neurogenesis and Neuritogenesis. Neural Plast (2016) 0.75
Rational therapeutic approaches to progressive supranuclear palsy. Brain (2010) 1.11
Systemic administration of neuregulin-1β1 protects dopaminergic neurons in a mouse model of Parkinson's disease. J Neurochem (2011) 0.94
Mechanisms of sleep-wake cycle modulation. CNS Neurol Disord Drug Targets (2009) 0.90
Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease. J Neuropathol Exp Neurol (2011) 0.89
Time perception distortion in neuropsychiatric and neurological disorders. CNS Neurol Disord Drug Targets (2013) 0.88
Caffeine and suicide: a systematic review. CNS Neurol Disord Drug Targets (2014) 0.88
Relationship between early and late stages of information processing: an event-related potential study. Neurol Int (2012) 0.84
Biodistribution and brain permeability of the extracellular domain of neuregulin-1-β1. Neuropharmacology (2011) 0.84
Psychosocial stress but not exercise increases cortisol and reduces state anxiety levels in school classes - results from a stressor applicable in large group settings. CNS Neurol Disord Drug Targets (2014) 0.84
Functional coupling of sensorimotor and associative areas during a catching ball task: a qEEG coherence study. Int Arch Med (2012) 0.84
EEG-based brain-computer interfaces: an overview of basic concepts and clinical applications in neurorehabilitation. Rev Neurosci (2010) 0.84
Epidemiology of early-onset dementia: a review of the literature. Clin Pract Epidemiol Ment Health (2013) 0.83
Natural toxins implicated in the development of Parkinson's disease. Ther Adv Neurol Disord (2011) 0.83
A new dopaminergic nigro-olfactory projection. Acta Neuropathol (2015) 0.82
Depression as a comorbidity in Behcet's syndrome. CNS Neurol Disord Drug Targets (2014) 0.82
Is mental practice an effective adjunct therapeutic strategy for upper limb motor restoration after stroke? A systematic review and meta- analysis. CNS Neurol Disord Drug Targets (2015) 0.81
Zonisamide: aspects in neuroprotection. Exp Neurol (2010) 0.81
Origin of the dopaminergic innervation of adult neurogenic areas. J Comp Neurol (2014) 0.81
Commentary: the effects of psychological stress on microglial cells in the brain. CNS Neurol Disord Drug Targets (2015) 0.81
Up-regulation of TLR-4 in the brain after ischemic kidney-induced encephalopathy in the rat. CNS Neurol Disord Drug Targets (2013) 0.81
Administration of URB597, oleoylethanolamide or palmitoylethanolamide increases waking and dopamine in rats. PLoS One (2011) 0.81
Olfactory neuron-specific expression of A30P α-synuclein exacerbates dopamine deficiency and hyperactivity in a novel conditional model of early Parkinson's disease stages. Neurobiol Dis (2011) 0.81
Treatment of Cognitive Deficits in Alzheimer's disease: A psychopharmacological review. Psychiatr Danub (2016) 0.81
Quantitative evaluation of the human subventricular zone. Brain (2012) 0.80
Changes in alpha band activity associated with application of the compression of fourth ventricular (CV-4) osteopathic procedure: a qEEG pilot study. J Bodyw Mov Ther (2012) 0.80
Co-enzyme Q10 to treat neurological disorders: basic mechanisms, clinical outcomes, and future research direction. CNS Neurol Disord Drug Targets (2013) 0.80
Intermittent maximal exercise improves attentional performance only in physically active students. Arch Med Res (2012) 0.80
Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa. CNS Neurol Disord Drug Targets (2014) 0.80
The value of repetitive transcranial magnetic stimulation (rTMS) for the treatment of anxiety disorders: an integrative review. CNS Neurol Disord Drug Targets (2011) 0.79
Motor neuron disease and acquired axonal neuropathy association in HIV infection: case report and update. Curr HIV Res (2012) 0.79
Chest pain, panic disorder and coronary artery disease: a systematic review. CNS Neurol Disord Drug Targets (2014) 0.79
Is rTMS an effective therapeutic strategy that can be used to treat anxiety disorders? Neuropharmacology (2011) 0.78
Bupropion in the depression-related sexual dysfunction: a systematic review. CNS Neurol Disord Drug Targets (2014) 0.78
Repetitive Transcranial Magnetic Stimulation (rTMS) to Treat Social Anxiety Disorder: Case Reports and a Review of the Literature. Clin Pract Epidemiol Ment Health (2013) 0.77
Reprogramming neurons by microRNAs into iPSCs to treat Parkinson's disease. Med Hypotheses (2011) 0.77
Premotor and occipital theta asymmetries as discriminators of memory- and stimulus-guided tasks. Brain Res Bull (2011) 0.77
Executive function impairments in patients with depression. CNS Neurol Disord Drug Targets (2014) 0.77
Single neuron electroporation in manipulating and measuring the central nervous system. Int Arch Med (2010) 0.77
Repetitive transcranial magnetic stimulation to treat substance use disorders and compulsive behavior. CNS Neurol Disord Drug Targets (2015) 0.77
A software tool for the analysis of neuronal morphology data. Int Arch Med (2014) 0.77
Oxidative Stress and Adult Neurogenesis. Stem Cell Rev (2015) 0.76
Effects of Aerobic Exercise on Anxiety Disorders: A Systematic Review. CNS Neurol Disord Drug Targets (2015) 0.76
Cortical reorganization after hand immobilization: the beta qEEG spectral coherence evidences. PLoS One (2013) 0.76
The effects of bromazepam over the temporo-parietal areas during the performance of a visuomotor task: a qEEG study. Neurosci Lett (2011) 0.76
Colchicine protects dopaminergic neurons in a rat model of Parkinson's disease. CNS Neurol Disord Drug Targets (2012) 0.76
From Mind to Body: Is Mental Practice Effective on Strength Gains? A Meta-Analysis. CNS Neurol Disord Drug Targets (2015) 0.76
Current pharmacological interventions in panic disorder. CNS Neurol Disord Drug Targets (2014) 0.76
Clonazepam for the treatment of panic disorder. Curr Drug Targets (2013) 0.76
Does immobilization of dependent hand promote adaptative changes in cerebral cortex? An analysis through qEEG asymmetry. Neurosci Lett (2012) 0.76
Sex therapy for female sexual dysfunction. Int Arch Med (2013) 0.76
Locally induced neural stem cells/pluripotent stem cells for in vivo cell replacement therapy. Int Arch Med (2008) 0.76
Extremely low-frequency electromagnetic fields activate the antioxidant pathway Nrf2 in a Huntington's disease-like rat model. Brain Stimul (2012) 0.76
rTMS to treat social anxiety disorder: a case report. Rev Bras Psiquiatr (2013) 0.76
Can Transcranial Direct Current Stimulation Improve the Resistance Strength and Decrease the Rating Perceived Scale in Recreational Weight-Training Experience? J Strength Cond Res (2016) 0.76
Neural Mechanisms of Exercise: Anti-Depression, Neurogenesis, and Serotonin Signaling. CNS Neurol Disord Drug Targets (2015) 0.75
Commentary: Adult-born neurons with unique GABAergic synapses. CNS Neurol Disord Drug Targets (2013) 0.75
Panic attack triggering myocardial ischemia documented by myocardial perfusion imaging study. A case report. Int Arch Med (2012) 0.75
Effects of Methylphenidate on performance of a practical pistol shooting task: a quantitative electroencephalography (qEEG) study. Int Arch Med (2011) 0.75
Effects of Exercise on Physical and Mental Health, and Cognitive and Brain Functions in Schizophrenia: Clinical and Experimental Evidence. CNS Neurol Disord Drug Targets (2015) 0.75
Utilizing neuro-inflammation: turning degeneration to regeneration. CNS Neurol Disord Drug Targets (2012) 0.75
Cellular viability effects of fatty acid amide hydrolase inhibition on cerebellar neurons. Int Arch Med (2011) 0.75
Research highlights. The genetic basis of "running for longevity". CNS Neurol Disord Drug Targets (2012) 0.75
The sleep-wake cycle, the hypocretin/orexin system and narcolepsy: advances from preclinical research to treatment. CNS Neurol Disord Drug Targets (2009) 0.75
Aerobic Exercise Does Not Predict Brain Derived Neurotrophic Factor And Cortisol Alterations in Depressed Patients. CNS Neurol Disord Drug Targets (2015) 0.75
Potential Therapeutic Effects of Physical Exercise for Bipolar Disorder. CNS Neurol Disord Drug Targets (2015) 0.75
Analysis of slow- and fast-α band asymmetry during performance of a saccadic eye movement task: dissociation between memory- and attention-driven systems. J Neurol Sci (2011) 0.75
A 6-Year Posttreatment Follow-up of Panic Disorder Patients: Treatment With Clonazepam Predicts Lower Recurrence Than Treatment With Paroxetine. J Clin Psychopharmacol (2017) 0.75
Characterization of Mitogen-Activated Protein Kinase Expression in Nucleus Accumbens and Hippocampus of Rats Subjected to Food Selection in the Cafeteria Diet Protocol. CNS Neurol Disord Drug Targets (2016) 0.75
Hemispheric differences over frontal theta-band power discriminate between stimulus- versus memory-driven saccadic eye movement. Neurosci Lett (2011) 0.75
Neural stem cells and neurodegeneration. CNS Neurol Disord Drug Targets (2012) 0.75
Evidence of nestin-positive cells in the human cutaneus Meissner and Pacinian corpuscles. CNS Neurol Disord Drug Targets (2012) 0.75
Neuroscience of Exercise: Association Among Neurobiological Mechanisms and Mental Health. CNS Neurol Disord Drug Targets (2015) 0.75
Repetitive transcranial magnetic stimulation (rTMS) to treat refractory panic disorder patient: a case report. CNS Neurol Disord Drug Targets (2014) 0.75
Activity-Dependent Neurorehabilitation Beyond Physical Trainings: "Mental Exercise" Through Mirror Neuron Activation. CNS Neurol Disord Drug Targets (2015) 0.75
Comparison Among Aerobic Exercise and Other Types of Interventions to Treat Depression: A Systematic Review. CNS Neurol Disord Drug Targets (2015) 0.75
Neural Mechanism of Exercise: Neurovascular Responses to Exercise. CNS Neurol Disord Drug Targets (2015) 0.75
Neural Mechanisms of Exercise: Effects on Gut Miccrobiota and Depression. CNS Neurol Disord Drug Targets (2015) 0.75
Clinical implication of Meissner`s corpuscles. CNS Neurol Disord Drug Targets (2012) 0.75
Colchicine as a promising drug for Parkinson's disease. Med Hypotheses (2010) 0.75
Changes of synaptic plasticity in multiple sclerosis. CNS Neurol Disord Drug Targets (2015) 0.75
Nanomaterials for Neurology: State-of-the-Art. CNS Neurol Disord Drug Targets (2016) 0.75
Neurological aspects of grief. CNS Neurol Disord Drug Targets (2014) 0.75
Neurobiology of Bipolar Disorder: Abnormalities on Cognitive and Cortical Functioning and Biomarker Levels. CNS Neurol Disord Drug Targets (2016) 0.75
Cognitive mechanisms and motor control during a saccadic eye movement task: evidence from quantitative electroencephalography. Arq Neuropsiquiatr (2012) 0.75
[Hypocretins, peptides associated with narcolepsy]. Gac Med Mex (2008) 0.75